Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 891

1.

Risk factors for episodes of back pain in emerging adults. A systematic review.

Øiestad BE, Hilde G, Tveter AT, Peat GG, Thomas MJ, Dunn KM, Grotle M.

Eur J Pain. 2019 Aug 21. doi: 10.1002/ejp.1474. [Epub ahead of print] Review.

PMID:
31433541
2.

Automatic segmentation of intravital fluorescence microscopy images by K-means clustering of FLIM phasors.

Zhang Y, Hato T, Dagher PC, Nichols EL, Smith CJ, Dunn KW, Howard SS.

Opt Lett. 2019 Aug 15;44(16):3928-3931. doi: 10.1364/OL.44.003928.

PMID:
31415514
3.

Clinical progression and outcome of individuals with and without swallowing impairment following non-traumatic subarachnoid haemorrhage: A retrospective cohort study.

Dunn K, Rumbach A.

Int J Speech Lang Pathol. 2019 Aug 8:1-11. doi: 10.1080/17549507.2019.1648552. [Epub ahead of print]

PMID:
31394986
4.

Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence.

Dunn KE, Huhn AS, Bergeria CL, Gipson CD, Weerts EM.

J Pharmacol Exp Ther. 2019 Aug 7. pii: jpet.119.258004. doi: 10.1124/jpet.119.258004. [Epub ahead of print]

5.

Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing Individuals.

Hammond AS, Dunn KE, Strain EC.

J Addict Med. 2019 Aug 2. doi: 10.1097/ADM.0000000000000542. [Epub ahead of print]

PMID:
31385846
6.

Dysphagia in non-traumatic subarachnoid haemorrhage: a scoping review.

Dunn K, Rumbach A, Finch E.

Neurosurg Rev. 2019 Aug 3. doi: 10.1007/s10143-019-01155-8. [Epub ahead of print] Review.

PMID:
31377942
7.

Buprenorphine in the United States: Motives for abuse, misuse, and diversion.

Chilcoat HD, Amick HR, Sherwood MR, Dunn KE.

J Subst Abuse Treat. 2019 Sep;104:148-157. doi: 10.1016/j.jsat.2019.07.005. Epub 2019 Jul 12.

PMID:
31370979
8.

Cancerous inhibitor of protein phosphatase 2A (CIP2A) modifies energy metabolism via 5' AMP-activated protein kinase signalling in malignant cells.

Austin JA, Jenkins RE, Austin GM, Glenn MA, Dunn K, Scott L, Lucas CM, Clark RE.

Biochem J. 2019 Aug 15;476(15):2255-2269. doi: 10.1042/BCJ20190121.

PMID:
31350330
9.

The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawal.

Bergeria CL, Huhn AS, Tompkins DA, Bigelow GE, Strain EC, Dunn KE.

Drug Alcohol Depend. 2019 Sep 1;202:111-114. doi: 10.1016/j.drugalcdep.2019.05.010. Epub 2019 Jul 16.

PMID:
31336328
10.

Meeting the needs of patients with disabilities: how can we better prepare the new dental graduate?

Wilson KE, Dunn K, Holmes RD, Delgaty L.

Br Dent J. 2019 Jul;227(1):43-48. doi: 10.1038/s41415-019-0462-9.

PMID:
31300783
11.

Quantitative Kinetic Models from Intravital Microscopy: A Case Study Using Hepatic Transport.

Tavakoli M, Tsekouras K, Day R, Dunn KW, Pressé S.

J Phys Chem B. 2019 Aug 15. doi: 10.1021/acs.jpcb.9b04729. [Epub ahead of print]

PMID:
31298856
12.

Promoting a comprehensive understanding of the opioid epidemic.

Dunn KE.

Int Rev Psychiatry. 2018 Oct;30(5):89-90. doi: 10.1080/09540261.2018.1530168. No abstract available.

PMID:
31282809
13.

Subgrouping patients with sciatica in primary care for matched care pathways: development of a subgrouping algorithm.

Konstantinou K, Dunn KM, van der Windt D, Ogollah R, Jasani V, Foster NE; SCOPiC study team.

BMC Musculoskelet Disord. 2019 Jul 4;20(1):313. doi: 10.1186/s12891-019-2686-x.

14.

Gone But Not Forgotten: How VA Remembers.

Nathan S, Dunn KM.

Fed Pract. 2019 Jun;36(6):254-256. No abstract available.

15.

Factors associated with costs and health outcomes in patients with Back and leg pain in primary care: a prospective cohort analysis.

Kigozi J, Konstantinou K, Ogollah R, Dunn K, Martyn L, Jowett S.

BMC Health Serv Res. 2019 Jun 21;19(1):406. doi: 10.1186/s12913-019-4257-0.

16.

Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans Biofilm Formation.

Rodríguez López AL, Lee MR, Wang NB, Dunn KK, Sanchez H, Raman N, Andes DR, Lynn DM, Palecek SP.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e02653-18. doi: 10.1128/AAC.02653-18. Print 2019 Sep.

PMID:
31209011
17.

A Versatile, Portable Intravital Microscopy Platform for Studying Beta-cell Biology In Vivo.

Reissaus CA, Piñeros AR, Twigg AN, Orr KS, Conteh AM, Martinez MM, Kamocka MM, Day RN, Tersey SA, Mirmira RG, Dunn KW, Linnemann AK.

Sci Rep. 2019 Jun 11;9(1):8449. doi: 10.1038/s41598-019-44777-0.

18.

Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.

Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, Cohen S, Peleg S, Shamaly H, On A, Millman P, Abramas L, Ziv-Baran T, Grant S, Abitbol G, Dunn KA, Bielawski JP, Van Limbergen J.

Gastroenterology. 2019 Aug;157(2):440-450.e8. doi: 10.1053/j.gastro.2019.04.021. Epub 2019 Jun 4.

PMID:
31170412
19.

Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.

Kagan RM, Dunn KJ, Snell GP, Nettles RE, Kaufman HW.

AIDS Res Hum Retroviruses. 2019 Aug;35(8):698-709. doi: 10.1089/AID.2019.0063. Epub 2019 Jul 10.

PMID:
31169022
20.

Matching treatment options for risk sub-groups in musculoskeletal pain: a consensus groups study.

Protheroe J, Saunders B, Bartlam B, Dunn KM, Cooper V, Campbell P, Hill JC, Tooth S, Mallen CD, Hay EM, Foster NE.

BMC Musculoskelet Disord. 2019 Jun 1;20(1):271. doi: 10.1186/s12891-019-2587-z.

21.

Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder.

Huhn AS, Berry MS, Dunn KE.

Am J Addict. 2019 Jul;28(4):246-261. doi: 10.1111/ajad.12921. Epub 2019 May 26. Review.

PMID:
31131505
22.

Randomized comparison of two web-based interventions on immediate and 30-day opioid overdose knowledge in three unique risk groups.

Bergeria CL, Huhn AS, Dunn KE.

Prev Med. 2019 May 10. pii: S0091-7435(19)30174-4. doi: 10.1016/j.ypmed.2019.05.006. [Epub ahead of print]

PMID:
31078564
23.

Infection prevention in personal services settings: Evidence, gaps and the way forward.

Popalyar A, Stafford J, Ogunremi T, Dunn K.

Can Commun Dis Rep. 2019 Jan 3;45(1):1-11. doi: 10.14745/ccdr.v45i01a01. eCollection 2019 Jan 3.

24.

The National Advisory Committee on Infection Prevention and Control (NAC-IPC).

Ogunremi T, Dunn K, Johnston L, Embree J.

Can Commun Dis Rep. 2018 Nov 1;44(11):283-289. doi: 10.14745/ccdr.v44i11a03. eCollection 2018 Nov 1.

26.

Coculture of Endothelial Cells with Human Pluripotent Stem Cell-Derived Cardiac Progenitors Reveals a Differentiation Stage-Specific Enhancement of Cardiomyocyte Maturation.

Dunn KK, Reichardt IM, Simmons AD, Jin G, Floy ME, Hoon KM, Palecek SP.

Biotechnol J. 2019 Aug;14(8):e1800725. doi: 10.1002/biot.201800725. Epub 2019 May 14.

PMID:
30927511
27.

Segmentation of biological images containing multitarget labeling using the jelly filling framework.

Gadgil NJ, Salama P, Dunn KW, Delp EJ.

J Med Imaging (Bellingham). 2018 Oct;5(4):044006. doi: 10.1117/1.JMI.5.4.044006. Epub 2018 Nov 23.

PMID:
30840740
28.

Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction.

Martin N, Weiler JM, Pearlman D, Jacques L, Nunn C, Forth R, West S, Dunn K, O'Byrne PM.

J Asthma. 2019 Feb 22:1-10. doi: 10.1080/02770903.2019.1579344. [Epub ahead of print]

PMID:
30795705
29.

Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal.

Huhn AS, Tompkins DA, Campbell CM, Dunn KE.

Pain Med. 2019 Jan 25. doi: 10.1093/pm/pny295. [Epub ahead of print]

PMID:
30690594
30.

A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.

Tengstrand E, Zhang H, Liu N, Dunn K, Hsieh F.

Toxicol Appl Pharmacol. 2019 Mar 1;366:54-63. doi: 10.1016/j.taap.2019.01.012. Epub 2019 Jan 15.

31.
32.

Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use.

Hay KR, Huhn AS, Tompkins DA, Dunn KE.

J Addict Med. 2019 Jul/Aug;13(4):300-305. doi: 10.1097/ADM.0000000000000498.

PMID:
30633045
33.

How women living with HIV react and respond to learning about Canadian law that criminalises HIV non-disclosure: 'how do you prove that you told?'

Greene S, Odhiambo AJ, Muchenje M, Symington A, Cotnam J, Dunn K, Frank M, Glum S, Gormley R, Ion A, Nicholson V, Shore K, Kaida A.

Cult Health Sex. 2019 Jan 9:1-16. doi: 10.1080/13691058.2018.1538489. [Epub ahead of print]

PMID:
30624133
34.

Risk of adverse events in patients prescribed long-term opioids: A cohort study in the UK Clinical Practice Research Datalink.

Bedson J, Chen Y, Ashworth J, Hayward RA, Dunn KM, Jordan KP.

Eur J Pain. 2019 May;23(5):908-922. doi: 10.1002/ejp.1357. Epub 2019 Jan 31.

PMID:
30620116
35.

AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival.

Cosimo E, Tarafdar A, Moles MW, Holroyd AK, Malik N, Catherwood MA, Hay J, Dunn KM, Macdonald AM, Guichard SM, O'Rourke D, Leach MT, Sansom OJ, Cosulich SC, McCaig AM, Michie AM.

Clin Cancer Res. 2019 Mar 1;25(5):1574-1587. doi: 10.1158/1078-0432.CCR-18-2036. Epub 2018 Dec 17.

PMID:
30559170
36.

Systematic review of sex-based differences in opioid-based effects.

Huhn AS, Berry MS, Dunn KE.

Int Rev Psychiatry. 2018 Oct;30(5):107-116. doi: 10.1080/09540261.2018.1514295. Epub 2018 Dec 6.

PMID:
30522374
37.

A simple automated method for continuous fieldwise measurement of microvascular hemodynamics.

Clendenon SG, Fu X, Von Hoene RA, Clendenon JL, Sluka JP, Winfree S, Mang H, Martinez M, Filson AJ, Klaunig JE, Glazier JA, Dunn KW.

Microvasc Res. 2019 May;123:7-13. doi: 10.1016/j.mvr.2018.11.010. Epub 2018 Nov 28.

PMID:
30502365
38.

The prevalence and general health status of people with intellectual disabilities and autism co-occurring together: a total population study.

Dunn K, Rydzewska E, MacIntyre C, Rintoul J, Cooper SA.

J Intellect Disabil Res. 2019 Apr;63(4):277-285. doi: 10.1111/jir.12573. Epub 2018 Nov 28.

PMID:
30488508
39.

Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.

Falk DE, Ryan ML, Fertig JB, Devine EG, Cruz R, Brown ES, Burns H, Salloum IM, Newport DJ, Mendelson J, Galloway G, Kampman K, Brooks C, Green AI, Brunette MF, Rosenthal RN, Dunn KE, Strain EC, Ray L, Shoptaw S, Ait-Daoud Tiouririne N, Gunderson EW, Ransom J, Scott C, Leggio L, Caras S, Mason BJ, Litten RZ; National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group.

Alcohol Clin Exp Res. 2019 Jan;43(1):158-169. doi: 10.1111/acer.13917. Epub 2018 Dec 9.

PMID:
30403402
40.

A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder.

Huhn AS, Strain EC, Tompkins DA, Dunn KE.

Drug Alcohol Depend. 2018 Dec 1;193:142-147. doi: 10.1016/j.drugalcdep.2018.10.002. Epub 2018 Oct 18.

PMID:
30384321
41.

Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients.

Huhn AS, Sweeney MM, Brooner RK, Kidorf MS, Tompkins DA, Ayaz H, Dunn KE.

Neuropsychopharmacology. 2019 Mar;44(4):826-833. doi: 10.1038/s41386-018-0252-0. Epub 2018 Oct 30.

PMID:
30375498
42.

Bayesian Inference of Microbial Community Structure from Metagenomic Data Using BioMiCo.

Dunn KA, Andrews K, Bashwih RO, Bielawski JP.

Methods Mol Biol. 2018;1849:267-289. doi: 10.1007/978-1-4939-8728-3_17.

PMID:
30298260
43.

Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.

Dunn KE, Weerts EM, Huhn AS, Schroeder JR, Tompkins DA, Bigelow GE, Strain EC.

Addict Biol. 2018 Oct 8. doi: 10.1111/adb.12680. [Epub ahead of print]

PMID:
30295400
44.

Use of Continuing Education to Increase Nurses' Knowledge of Chronic Wound Care Management.

Goudy-Egger L, Dunn KS.

J Contin Educ Nurs. 2018 Oct 1;49(10):454-459. doi: 10.3928/00220124-20180918-05.

PMID:
30257028
45.

Modeling of xenobiotic transport and metabolism in virtual hepatic lobule models.

Fu X, Sluka JP, Clendenon SG, Dunn KW, Wang Z, Klaunig JE, Glazier JA.

PLoS One. 2018 Sep 13;13(9):e0198060. doi: 10.1371/journal.pone.0198060. eCollection 2018.

46.

Back pain, mental health and substance use are associated in adolescents.

Kamper SJ, Michaleff ZA, Campbell P, Dunn KM, Yamato TP, Hodder RK, Wiggers J, Williams CM.

J Public Health (Oxf). 2018 Sep 10. doi: 10.1093/pubmed/fdy129. [Epub ahead of print]

PMID:
30204888
47.

Targeting quiescent leukemic stem cells using second generation autophagy inhibitors.

Baquero P, Dawson A, Mukhopadhyay A, Kuntz EM, Mitchell R, Olivares O, Ianniciello A, Scott MT, Dunn K, Nicastri MC, Winkler JD, Michie AM, Ryan KM, Halsey C, Gottlieb E, Keaney EP, Murphy LO, Amaravadi RK, Holyoake TL, Helgason GV.

Leukemia. 2019 Apr;33(4):981-994. doi: 10.1038/s41375-018-0252-4. Epub 2018 Sep 5.

48.

Towards a Bioelectronic Computer: A Theoretical Study of a Multi-Layer Biomolecular Computing System That Can Process Electronic Inputs.

Dunn KE, Trefzer MA, Johnson S, Tyrrell AM.

Int J Mol Sci. 2018 Sep 4;19(9). pii: E2620. doi: 10.3390/ijms19092620.

49.

Misdiagnosis of Leiomyosarcoma after Radiofrequency Ablation of Uterine Myomas.

Varon S, Parvataneni R, Waetjen E, Dunn K, Jacoby VL.

J Minim Invasive Gynecol. 2019 Mar - Apr;26(3):564-566. doi: 10.1016/j.jmig.2018.08.004. Epub 2018 Aug 17.

PMID:
30121386
50.

Incidence and Risk Factors for Dysphagia Following Non-traumatic Subarachnoid Hemorrhage: A Retrospective Cohort Study.

Dunn K, Rumbach A.

Dysphagia. 2019 Apr;34(2):229-239. doi: 10.1007/s00455-018-9934-3. Epub 2018 Aug 7.

PMID:
30088089

Supplemental Content

Support Center